课题基金 / 基金详情

Colon-Specific Drug Delivery System Based on Cyclodextrin Conjugate

Colon-Specific Drug Delivery System Based on Cyclodextrin Conjugate
基于环糊精缀合物的结肠特异性给药系统
批准号:
09672331
负责人:
UEKAMA Kaneto
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

UEKAMA Kaneto的其他基金

相似基金

相关文献

中文摘要
翻译
以α-、β-和γ-环糊精(α-、β-和γ-CyD)为模型药物,通过酯键或酰胺键将β-联苯乙酸(BPAA)选择性地偶联到α-、β-和γ-环糊精的伯羟基之一上(BPAA/α-、β-和γ-CyD偶联物)。并对其体内外释药、口服吸收及大鼠模型释药效果进行了研究,以评价其作为结肠定位给药系统的可行性。1)NMR和质谱分析结果表明,BPAA被选择性地引入到CyDs的一个伯羟基上。α-和β-CyD偶联物的水溶性分别约为BPAA的100倍和10倍,而BPAA的水溶性分别约为BPAA的100倍和10倍。的β-CyD缀合物降低到约十分之一。该酯缀合物在大鼠盲肠和结肠内容物中选择性地释放BPAA,而它们在大鼠的其他生物体液中是稳定的。2)口服给药α-和-γ-CyD酯缀合物后约3小时,BPAA的血清水平增加,伴随着血清水平的显著增加,而β-CyD和酰胺缀合物导致血清水平几乎没有增加。3)与β-CyD复合物相比,评价γ-CyD酯缀合物的抑制作用,采用角叉菜胶诱导的大鼠足急性水肿模型。在β-CyD复合物的情况下,由于复合物的快速溶解,观察到快速的荧光反应。与此形成鲜明对比的是,γ-CyD偶联物需要相当长的滞后时间才能表现出药物递送,因为BPAA是在到达盲肠和结肠之后产生的。
英文摘要
An antiinflammatory 4-biphenylylacetic acid (BPAA), as a model drug, was selectively conjugated onto one of the primary hydroxyl groups of alpha-, beta- and gamma-cyclodextrins (alpha-, beta- and gamma-CyDs) though an ester or amide linkage, (BPAA/alpha-, beta- and gamma-CyD conjugates). and their in-vitro and in- vivo drug release, oral absorption behavior, and antiinflammatory effect in rat model were investigate to evaluate them as a colon-specific drug delivery system. The results obtained were summarized as follows :1) The NMR and mass spectroscopic results indicate that the BPAA moiety was introduced selectively onto one of the primary hydroxyl groups of CyDs. The aqueous solubilities of the alpha- and beta-CyD conjugates were about 100 and 10 times respectively, that of BPAA, whereas that. of the beta-CyD conjugate decreased to about one-tenth. The ester conjugates released BPAA selectively in rat cecal and colonic contents, whereas they were stable in other biological fluids of rats.2) The serum levels of BPAA increased about 3 hours after oral administration of the alpha-and -gamma-CyD ester conjugates to rats, accompanying a marked increase in the serum levels, whereas the beta-CyD and the amide conjugates resulted in little increase of the serum levels.3) The antiinflammatory effect of the gamma-CyD ester conjugate was evaluated, in comparison with that of the beta-CyD complex, using the model of carageenan-induced acute edema in rat paw. In the case of the beta-CyD complex a rapid antiinflammatory response was observed, because of the fast dissolution of the complex. In sharp contrast, the gamma-CyD conjugate needed a fairly long lag time to exhibit, the drug delivery, because BPAA was produced after it had reached the cecum and colon.The present conjugate approach provides a versatile means for construction of not only colon-specific delivery system but also delay-release system of certain drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
F.Hirayama: "In-vitro Evaluation of Biphenylyl Acetic Acid-β-Cyclodextrin Conjugates as Colon-Targeting Prodrug: Drug Release Behaviour in Rat Biological Media" J.Pharm.Pharmacol.48・1. 27-31 (1996)
F. Hirayama:“联苯乙酸-β-环糊精缀合物作为结肠靶向前药的体外评价:大鼠生物介质中的药物释放行为”J.Pharm.Pharmacol.48・1(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Minami: "Colon-Specific Drug Delivery Based on a Cyclo-dextrin Prodrug : Release Behavior of Biphenylylacetic Acid from Its Cyclodextrin Conjugates in Rat Intestinal Tracts after Oral Administration" J.Pharm.Sci.87 (6). 715-720 (1998)
K.Minami:“基于环糊精前药的结肠特异性药物递送:口服给药后联苯乙酸从其环糊精缀合物在大鼠肠道中的释放行为”J.Pharm.Sci.87 (6)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Irie: "Pharmaceutical Applications of Cyclodextrins.III: Toxicological Issues and Safety Evaluation" J.Pharm.Sci.86・2. 147-162 (1997)
T.Irie:“环糊精的药物应用.III:毒理学问题和安全性评估”J.Pharm.Sci.86・2 147-162(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Uekama: "6 -O-[(4-Biphenylyl)acetyl]-α-,-β-,and -r-cyclodextrins and 6 -deoxy-6-[(4-biphenylyl)acetyl] amino]-α-,-β-,and -r-cyclodextrins : Potential Prodrugs for Colon-Specific Delivery" J.Med.Chem.40・17. 2755-2761 (1997)
K.Uekama:“6-O-[(4-联苯基)乙酰基]-α-、-β-和-r-环糊精和6-脱氧-6-[(4-联苯基)乙酰基]氨基]-α- ,-β-,和-r-环糊精:用于结肠特异性递送的潜在前药”J.Med.Chem.40・17.2755-2761 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Potential use of supramolecular cyclodextrins for the design of patient- friendly super-generic drug formulations
    • 批准号:
      22590164
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      UEKAMA Kaneto
    • 依托单位:
    Potential Use of Cyclodextrins in the Development of Patient-Friendly Super-Generic Preparations
    • 批准号:
      19590169
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      UEKAMA Kaneto
    • 依托单位:
    Development of High-performance Cyclic-oligosaccharide-Based Peptide/protein Delivery System Having Biodegradable Characteristics
    • 批准号:
      12557206
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2000
    • 负责人:
      UEKAMA Kaneto
    • 依托单位:
    Design and Evaluation of Cyclic-oligosaccharide-Based Colon Specific Delivery System Having Biodegradable Characteristics
    • 批准号:
      11672265
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      1999
    • 负责人:
      UEKAMA Kaneto
    • 依托单位:
    海外基金